StemExpress
Latest round
- Seed
Last raised
- Jun 2018
Total raised
- Undisclosed
Investors
- 2
About StemExpress
StemExpress, LLC was founded in 2010 in Folsom, US. The company focuses on supplying a range of cellular products including Leukopaks and other blood products to research institutions and biotechnology firms. Cate Dyer serves as the CEO and has an extensive background in the biotech industry.StemExpress offers a comprehensive range of cellular products and services that play a crucial role in advancing cell and gene therapy research. Their core offerings include healthy and disease state Leukopaks, mobilized Leukopaks, and various blood and cellular products such as bone marrow, cord blood, and isolated cells. These products are primarily utilized by research institutions, biotechnology firms, and pharmaceutical companies involved in clinical trials and therapeutic development, adhering to Good Manufacturing Practice (GMP) regulations.StemExpress operates under a B2B model, partnering with research organizations and biotechnology firms for transactions involving clinical-grade cellular products. Clients request specific volumes and types according to their research needs, with pricing structures tailored accordingly. The company aims to enhance its product lineup and increase its geographical reach, particularly targeting the North American and European markets within the next few years.
Who invested in StemExpress
2 investors across 1 round
See all investors in StemExpress
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 22, 2018
Amount
Undisclosed
Investors
Questions about StemExpress
Who invested in StemExpress?
StemExpress has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has StemExpress raised?
StemExpress has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did StemExpress last raise money?
StemExpress's most recent round on record is a Seed, in Jun 2018.
What does StemExpress do?
StemExpress, LLC was founded in 2010 in Folsom, US.
Where is StemExpress headquartered?
StemExpress is headquartered in Folsom, US.
Which VCs invest in companies like StemExpress?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at StemExpress's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like StemExpress? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.